EM ETFs Laugh in the Face of Fed Balance Sheet Normalization
(Bloomberg) -- As investors waited on tenterhooks Wednesday afternoon to hear what -- if anything -- the Federal Reserve had to say about balance sheet normalization, what'd they do?
Bought emerging market exchange-traded funds, of course.
The Vanguard FTSE Emerging Markets ETF, best known by the symbol VWO, topped the leader board for U.S. equity fund flows, raking in $872.5 million for the day. In second place: BlackRock Inc.'s iShares Core MSCI Emerging Markets ETF, ticker IEMG, which received the most inflows during the first quarter.
Tighter monetary policy from the Fed, commonly deemed the world's central bank, tends to have an adverse effect on global liquidity. In the past, that's been particularly bad news for emerging markets, which also have sizable holdings of U.S. dollar-denominated debt.
The spread of unconventional monetary policy has helped spur capital inflows to emerging markets in the post-crisis era. They were acutely rocked by the “taper tantrum” of 2013, in which the Fed suggested it would be dialing back its asset purchases by year-end.
But this time the prospects for an outright shrinkage of the central bank's close to $4.5 trillion balance sheet didn't faze markets one bit -- at least on Wednesday.
Oh, and what did investors dump as they gorged on emerging-market assets? The world's biggest ETF, State Street Corp.'s $232 billion SPDR S&P 500 ETF, better known as SPY, which suffered more than $2 billion in withdrawals.
To contact the reporter on this story: Luke Kawa in New York at lkawa@bloomberg.net.
To contact the editors responsible for this story: Jeremy Herron at jherron8@bloomberg.net, Eric J. Weiner, Dave Liedtka
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.